NICUSeq: A Trial to Evaluate the Clinical Utility of Human Whole Genome Sequencing (WGS) Compared to Standard of Care in Acute Care Neonates and Infants (NICU-Seq)
NICUSeq: A Prospective Trial to Evaluate the Clinical Utility of Human Whole Genome Sequencing (WGS) Compared to Standard of Care in Acute Care Neonates and Infants
Sponsor: Children's Hospital and Medical Center, Omaha, Nebraska
This NA trial investigates Rare Diseases and is currently completed. Children's Hospital and Medical Center, Omaha, Nebraska leads this study, which shows 11 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Dec 2020 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
▶ Show 6 earlier versions
-
Sep 2020 — Dec 2020 [monthly]
Active Not Recruiting NA
-
Jun 2019 — Sep 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2018 — Jun 2019 [monthly]
Recruiting NA
-
Jun 2018 — Sep 2018 [monthly]
Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Recruiting NA
-
Oct 2017 — Mar 2018 [monthly]
Recruiting NA
First recorded
Sep 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Children's Hospital and Medical Center, Omaha, Nebraska
- Children's Hospital of Orange County
- Children's Hospital of Philadelphia
- Illumina, Inc.
- Le Bonheur Children's Hospital
- Rady Pediatric Genomics & Systems Medicine Institute
- St. Louis Children's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .